✦ LIBER ✦

P1892 Management of pegylated interferon alpha and ribavirin induced neutropenia and thrombocytopenia in patients with chronic hepatitis C

✍ Scribed by Htwe, T.; Blessman, D.; Spain, M.; Adamski, A.; Mushtaq, A.; Koirala, J.; Khardori, N.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Feasibility of pegylated interferon and

✍ Iacobellis, Angelo; Cozzolongo, Raffaele; Minerva, Nicola; Valvano, Maria Rosa; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 429 KB

Thrombocytopenia in pegylated interferon

✍ Aizawa, Nobuhiro; Enomoto, Hirayuki; Takashima, Tomoyuki; Sakai, Yoshiyuki; Iwat 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 302 KB

Thrombocytopenia in pegylated interferon

✍ Aizawa, Nobuhiro; Enomoto, Hirayuki; Takashima, Tomoyuki; Sakai, Yoshiyuki; Iwat 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 302 KB

Dyspnoea in patients with chronic hepati

✍ Garib, Junia Rios; Garcia, Guilherme Freire; Teixeira, Rosângela; Lima e Silva, 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 151 KB

Commentary: efficacy and safety of ribav

✍ Hadziyannis, S. J.; Sevastianos, V. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Pegylated interferon-alpha 2b–ribavirin

✍ M. Derbala; A. Amer; A. Bener; A. C. Lopez; M. Omar; M. El Ghannam 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB